• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharming - Articles and news items

Pharming extends Ruconest distribution agreement with Cytobioteck

Industry news / 9 February 2016 / Victoria White

Under the extended agreement, Cytobioteck will also exclusively distribute Ruconest in Argentina, Costa Rica, the Dominican Republic and Panama…

Pharming completes patient enrolment in Phase 2 Ruconest trial

Industry news / 6 January 2016 / Victoria White

The Phase 2 clinical study will investigate Ruconest (recombinant C1 esterase Inhibitor, 50 IU/kg) for prophylaxis in patients with hereditary angioedema…

FDA grants HAE drug Ruconest 12-years of exclusivity

Industry news / 8 October 2015 / Victoria White

The exclusivity ensures that the FDA will not approve any applications for biosimilars of the drug before July 2026…